Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Cardiol Therapeutics Inc. (CRDL) had Weighted-Average Shares Outstanding (Diluted) of 114.94M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-4.39M |
|
-- |
|
-- |
|
$5.73M |
|
$-5.73M |
|
$1.34M |
|
$-4.39M |
|
$-4.39M |
|
$-4.39M |
|
$-4.39M |
|
$-4.39M |
|
$-4.39M |
|
$-5.73M |
|
$-5.73M |
|
114.94M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
114.94M |
$-0.04 |
|
$-0.04 |
|
| Balance Sheet Financials | |
$21.11M |
|
$0.09M |
|
$0.09M |
|
$21.21M |
|
$3.80M |
|
$0.05M |
|
$0.05M |
|
$3.85M |
|
$17.36M |
|
$17.36M |
|
$17.36M |
|
115.89M |
|
| Cash Flow Statement Financials | |
$-8.59M |
|
$-0.04M |
|
$11.61M |
|
$15.47M |
|
$18.84M |
|
$3.37M |
|
$3.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.55 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.63M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-25.31% |
|
-25.31% |
|
-20.72% |
|
-25.24% |
|
$0.15 |
|
$-0.08 |
|
$-0.07 |
|